Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 4 Interactions

Monitor/Modify Tx
azithromycin (generic) + Ubrelvy (ubrogepant)
Monitor/Modify Tx azithromycin + ubrogepant limit ubrogepant dose to 50 mg, may give second 50 mg dose after 2h if needed: combo may incr. ubrogepant levels, risk of adverse effects (P-gp-mediated transport inhibited)
Claritin-D 12 Hour (loratadine/ pseudoephedrine) + Micardis (telmisartan)
Monitor/Modify Tx pseudoephedrine + telmisartan monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)
Claritin-D 12 Hour (loratadine/ pseudoephedrine) + Ubrelvy (ubrogepant)
Monitor/Modify Tx pseudoephedrine + ubrogepant monitor BP: combo may incr. risk of HTN (additive effects)
Micardis (telmisartan) + Ubrelvy (ubrogepant)
Monitor/Modify Tx telmisartan + ubrogepant monitor BP; limit ubrogepant dose to 50 mg, may give second 50 mg dose after 2h if needed: combo may incr. ubrogepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited; antagonistic effects)
Additional Considerations
pseudoephedrine in Claritin-D 12 Hour
add MAO inhibitor to Interaction Check if recent (14 days) use